Among KRASms in NSCLC, the KRAS G12C mutation (KRASm G12C) is the most common (approximately 40%), followed by the KRAS G12V mutation (20%) and the KRAS G12D mutation (16%) (7, 8). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.